L3Harris Technologies, Inc.
LHX · NYSE
Analyst ratings
buy · 7 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| May 4, 2026 | Bernstein | Maintains | Outperform | $405.00 |
| May 1, 2026 | UBS | Maintains | Neutral | $330.00 |
| February 5, 2026 | Citigroup | Maintains | Buy | $418.00 |
| February 5, 2026 | JP Morgan | Maintains | Overweight | $395.00 |
| February 2, 2026 | Morgan Stanley | Maintains | Overweight | $390.00 |
| January 30, 2026 | RBC Capital | Maintains | Sector Perform | $365.00 |
| January 15, 2026 | UBS | Maintains | Neutral | $349.00 |
| January 14, 2026 | RBC Capital | Maintains | Sector Perform | $360.00 |
| January 13, 2026 | Citigroup | Maintains | Buy | $389.00 |
| December 16, 2025 | Morgan Stanley | Upgrades | Overweight | $367.00 |
| November 4, 2025 | JP Morgan | Maintains | Overweight | $340.00 |
| October 31, 2025 | UBS | Maintains | Neutral | $323.00 |
| October 15, 2025 | Truist Securities | Maintains | Buy | $353.00 |
| October 15, 2025 | Morgan Stanley | Maintains | Equal-Weight | $350.00 |
Valuation and intrinsic value gap
L3Harris Technologies trades at a significant discount to its intrinsic value, with the most followed analyst narrative pegging fair value at $381.95 — a 24.1% premium to recent closing prices. Steady revenue expansion, rising margins, and an earnings multiple below sector peers support the case for meaningful upside.
Despite the apparent valuation gap, the stock has suffered sharp near-term price erosion — down 5.9% over 30 days and 18% over 90 days. Technical indicators confirm strong selling pressure, with the share price trading below its 5, 20, and 50-day exponential moving averages, signaling continued downside risk.
Defense budget dependency and contract execution risk
Recent contract wins with the U.S. Space Force, Army, and NGC2 program demonstrate a robust government pipeline. L3Harris has beaten earnings estimates for three consecutive quarters, and the planned IPO of its missile solutions business could unlock additional shareholder value, reinforcing confidence in its execution capabilities.
L3Harris faces elevated execution risk on fixed-price development contracts, which can compress margins if costs overrun. Tighter U.S. and European defense budget constraints pose a structural headwind, and heavy reliance on government spending cycles makes revenue visibility fragile in a fiscally constrained environment.
Long-term growth trajectory vs. near-term momentum concerns
Over a 36-year historical sample, L3Harris stock has risen in 69.44% of subsequent 52-week periods, with an average annual gain of 14.7%. Analysts project earnings increases of $1.13 per share this year and $1.85 per share next year, supporting a long-term price forecast of $323.37 over the next 52 weeks.
Despite optimistic long-run projections, the current Financhill Stock Score of 47/100 sits below its historic median, inferring above-average risk. Short-term technical indicators are firmly negative, and the stock's score in the 40–50th percentile range relative to its own history suggests deteriorating momentum and limited near-term catalysts.